| 摘要 |
<p>The invention concerns a pharmaceutical composition comprising a DNA molecule containing a sequence coding for a peptide or polypeptide derived from Helicobacter, in particular from Helicobacter pylori, placed under the control of elements required for its expression in a mammal's cell. The polypeptide can in particular be Helicobacter, particularly Helicobacter pylori, urease A or B subunit. Said composition is useful for treating or preventing Helicobacter, in particular Helicobacter pylori, infection.</p> |
